High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer
Open Access
- 10 November 2009
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 127 (2), 355-360
- https://doi.org/10.1002/ijc.25034
Abstract
CCND1 encodes for the cyclin D1 protein involved in G1/S cell cycle transition. In breast cancer the mechanism of CCND1 amplification, relationship between cyclin D1 protein expression and the key clinical markers estrogen receptor (ER) and HER2 requires elucidation. Tissue microarrays of primary invasive breast cancer from 93 women were evaluated for CCND1 amplification by fluorescent in‐situ hybridization and cyclin D1 protein overexpression by immunohistochemistry. CCND1 amplification was identified in 27/93 (30%) cancers and 59/93 (63%) cancers had overexpression of cyclin D1. CCND1 amplification was significantly associated with cyclin D1 protein overexpression (p < 0.001; Fisher's exact test) and both CCND1 amplification and cyclin D1 protein expression with oestrogen receptor (ER) expression (p = 0.003 and p < 0.001; Fishers exact test). Neither CCND1 amplification nor cyclinD1 expression was associated with tumor size, pathological node status or HER2 amplification, but high CCND1 amplification (Copy Number Gain (CNG) ≥ 8) was associated with high tumor grade (p = 0.005; chi square 7.915, 2 df) and worse prognosis by Nottingham Prognostic Index (p = 0.001; 2 sample t‐test). High CCND1 amplification (CNG ≥ 8) may identify a subset of patients with poor prognosis ER‐positive breast cancers who should be considered for additional therapy.Keywords
This publication has 29 references indexed in Scilit:
- Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumorsInternational Journal of Cancer, 2009
- CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysisBreast Cancer Research and Treatment, 2008
- Trastuzumab in the Treatment of Breast CancerThe New England Journal of Medicine, 2005
- Trastuzumab and Breast Cancer. Are we just Beyond the Prologue of a Fascinating Story?Oncology Research and Treatment, 2005
- Cyclin D1, EMS1 and 11q13 Amplification in Breast CancerBreast Cancer Research and Treatment, 2003
- Genetic instability of cancer cells is proportional to their degree of aneuploidyProceedings of the National Academy of Sciences of the United States of America, 1998
- c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle ReentryMolecular and Cellular Biology, 1998
- Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†Molecular and Cellular Biology, 1997
- CDK-Independent Activation of Estrogen Receptor by Cyclin D1Cell, 1997
- Cyclin D1 is a nuclear protein required for cell cycle progression in G1.Genes & Development, 1993